These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring. Halaby CA; Young SP; Austin S; Stefanescu E; Bali D; Clinton LK; Smith B; Pendyal S; Upadia J; Schooler GR; Mavis AM; Kishnani PS Genet Med; 2019 Dec; 21(12):2686-2694. PubMed ID: 31263214 [TBL] [Abstract][Full Text] [Related]
7. Does increased fatty acid oxidation enhance development of liver cirrhosis and progression to hepatocellular carcinoma in patients with glycogen storage disease type-III? Herrema H; Smit GP; Reijngoud DJ; Kuipers F J Hepatol; 2007 Aug; 47(2):298-300; author reply 300-1. PubMed ID: 17570555 [No Abstract] [Full Text] [Related]
8. [Diagnosis of glycogen storage disease type IIIA by detecting glycogen debranching enzyme activity, glycogen content and structure in muscle]. Wang W; We M; Song HM; Qiu ZQ; Zhang WM; Wu XY; Lu CX; Qi JM; Jing H; Li F Zhonghua Er Ke Za Zhi; 2009 Aug; 47(8):608-12. PubMed ID: 19951495 [TBL] [Abstract][Full Text] [Related]
9. Liver transplantation in patients with type IIIa glycogen storage disease, cirrhosis and hepatocellular carcinoma. Iglesias Jorquera E; Tomás Pujante P; Ruiz García G; Vargas Acosta ÁM; Pons Miñano JA Rev Esp Enferm Dig; 2019 Feb; 111(2):168-169. PubMed ID: 30318896 [TBL] [Abstract][Full Text] [Related]
10. Natural Progression of Canine Glycogen Storage Disease Type IIIa. Brooks ED; Yi H; Austin SL; Thurberg BL; Young SP; Fyfe JC; Kishnani PS; Sun B Comp Med; 2016 Feb; 66(1):41-51. PubMed ID: 26884409 [TBL] [Abstract][Full Text] [Related]
11. Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports. Manzia TM; Angelico R; Toti L; Cillis A; Ciano P; Orlando G; Anselmo A; Angelico M; Tisone G Transplant Proc; 2011 May; 43(4):1181-3. PubMed ID: 21620082 [TBL] [Abstract][Full Text] [Related]
12. Case report: rupture of a gastric varix in liver cirrhosis associated with glycogen storage disease type III. Hashimoto M; Watanabe G; Yokoyama T; Tsutsumi K; Dohi T; Matsuda M; Okubo M; Nakamura N; Tsurumaru M J Gastroenterol Hepatol; 1998 Feb; 13(2):232-5. PubMed ID: 10221829 [TBL] [Abstract][Full Text] [Related]
13. A case of glycogen storage disease type III (glycogen debranching enzyme deficiency) with liver cirrhosis and hypertrophic cardiomyopathy. Kobayashi A; Nishinomiya F; Fukamachi Y; Ohtaka M; Yamamoto J; Takagi K; Tanaka S; Takizawa S; Imadachi H; Fukase M Tohoku J Exp Med; 1995 Jul; 176(3):181-5. PubMed ID: 8553356 [TBL] [Abstract][Full Text] [Related]
14. Development of Hepatocellular Carcinoma in Patients with Glycogen Storage Disease: a Single Center Retrospective Study. Jang HJ; Yang HR; Ko JS; Moon JS; Chang JY; Seo JK J Korean Med Sci; 2020 Jan; 35(1):e5. PubMed ID: 31898434 [TBL] [Abstract][Full Text] [Related]
15. Activation of tumor-promoting pathways implicated in hepatocellular adenoma/carcinoma, a long-term complication of glycogen storage disease type Ia. Cho JH; Lee YM; Bae SH; Chou JY Biochem Biophys Res Commun; 2020 Jan; 522(1):1-7. PubMed ID: 31735334 [TBL] [Abstract][Full Text] [Related]
16. Glycogen storage disease type III in Egyptian children: a single centre clinico-laboratory study. El-Karaksy H; Anwar G; El-Raziky M; Mogahed E; Fateen E; Gouda A; El-Mougy F; El-Hennawy A Arab J Gastroenterol; 2014 Jun; 15(2):63-7. PubMed ID: 25097048 [TBL] [Abstract][Full Text] [Related]